---
title: "INKON Life released its first-quarter performance, with a net profit attributable to the parent company of 29.9927 million yuan, an increase of 14.36%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237808182.md"
description: "INKON Life released its Q1 2025 performance report, with operating revenue of 409 million yuan, a year-on-year decrease of 1.73%. The net profit attributable to the parent company was 29.9927 million yuan, a year-on-year increase of 14.36%; the net profit excluding non-recurring gains and losses was 29.9653 million yuan, a year-on-year increase of 25.77%. The basic earnings per share were 0.0404 yuan"
datetime: "2025-04-28T09:22:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237808182.md)
  - [en](https://longbridge.com/en/news/237808182.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237808182.md)
generator: "portal-rs"
---

# INKON Life released its first-quarter performance, with a net profit attributable to the parent company of 29.9927 million yuan, an increase of 14.36%

According to the Zhitong Finance APP, INKON Life (300143.SZ) released its first quarter report for 2025, showing an operating income of 409 million yuan, a year-on-year decrease of 1.73%. The net profit attributable to shareholders of the listed company was 29.9927 million yuan, a year-on-year increase of 14.36%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.9653 million yuan, a year-on-year increase of 25.77%. The basic earnings per share were 0.0404 yuan

### Related Stocks

- [300143.CN](https://longbridge.com/en/quote/300143.CN.md)

## Related News & Research

- [Avanti Helium secures up to US $10 million convertible credit facility with RiverFort Global Opportunities](https://longbridge.com/en/news/296806980.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Carvolix incorporates Saudi unit, eyes MedTech manufacturing plant in Riyadh](https://longbridge.com/en/news/296812392.md)
- [DEA restricts three synthetic kratom compounds citing public safety threat](https://longbridge.com/en/news/296934498.md)
- [Flexcon Announces Global Relaunch of PharmCal® BioMark with ISEGA Certification](https://longbridge.com/en/news/296800649.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**